Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -157,868 | -31,888 | -205,192 | -153,638 | -79,577 |
| Depreciation Amortization | 515 | 265 | 1,023 | 738 | 470 |
| Accounts receivable | -855 | 2,033 | -5,382 | -2,964 | -2,041 |
| Accounts payable and accrued liabilities | 4,728 | 3,735 | -4 | -3,252 | -2,821 |
| Other Working Capital | 1,084 | 5,405 | 10,578 | -3,974 | -8,940 |
| Other Operating Activity | 104,817 | -469 | 52,310 | 37,688 | 4,874 |
| Operating Cash Flow | $-47,579 | $-20,919 | $-146,667 | $-125,402 | $-88,035 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -236 | -66 | -2,939 | -2,886 | -2,289 |
| Net Acquisitions | N/A | N/A | 250 | 250 | 250 |
| Investing Cash Flow | $-236 | $-66 | $-2,689 | $-2,636 | $-2,039 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | N/A | N/A | N/A |
| Debt Repayment | -5,892 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 53,262 | 5,480 | 81,990 | 81,889 | 81,778 |
| Common Stock Repurchased | -18 | N/A | N/A | 0 | N/A |
| Other Financing Activity | -859 | -351 | 8,703 | -1,062 | -967 |
| Financing Cash Flow | $56,493 | $15,129 | $90,693 | $80,827 | $80,811 |
| Beginning Cash Position | 13,588 | 13,588 | 72,251 | 72,251 | 72,251 |
| End Cash Position | 22,266 | 7,732 | 13,588 | 25,040 | 62,988 |
| Net Cash Flow | $8,678 | $-5,856 | $-58,663 | $-47,211 | $-9,263 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,579 | -20,919 | -146,667 | -125,402 | -88,035 |
| Capital Expenditure | -236 | -66 | -2,939 | -2,886 | -2,289 |
| Free Cash Flow | -47,815 | -20,985 | -149,606 | -128,288 | -90,324 |